- Home
- CRDF vs FRST Comparison
CRDF vs FRST Comparison
Compare CRDF & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- FRST
- Stock Information
- Founded
- CRDF 1999
- FRST 2004
- Country
- CRDF United States
- FRST United States
- Employees
- CRDF N/A
- FRST N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- FRST Major Banks
- Sector
- CRDF Health Care
- FRST Finance
- Exchange
- CRDF Nasdaq
- FRST Nasdaq
- Market Cap
- CRDF 288.7M
- FRST 290.5M
- IPO Year
- CRDF N/A
- FRST 2006
- Fundamental
- Price
- CRDF $3.84
- FRST $10.33
- Analyst Decision
- CRDF Strong Buy
- FRST Buy
- Analyst Count
- CRDF 4
- FRST 1
- Target Price
- CRDF $12.00
- FRST $14.00
- AVG Volume (30 Days)
- CRDF 1.1M
- FRST 108.6K
- Earning Date
- CRDF 05-01-2025
- FRST 04-24-2025
- Dividend Yield
- CRDF N/A
- FRST 3.89%
- EPS Growth
- CRDF N/A
- FRST N/A
- EPS
- CRDF N/A
- FRST N/A
- Revenue
- CRDF $683,000.00
- FRST $107,704,000.00
- Revenue This Year
- CRDF N/A
- FRST $40.41
- Revenue Next Year
- CRDF N/A
- FRST $12.70
- P/E Ratio
- CRDF N/A
- FRST N/A
- Revenue Growth
- CRDF 39.96
- FRST N/A
- 52 Week Low
- CRDF $2.01
- FRST $9.52
- 52 Week High
- CRDF $6.42
- FRST $13.52
- Technical
- Relative Strength Index (RSI)
- CRDF 46.50
- FRST 48.61
- Support Level
- CRDF $3.52
- FRST $10.01
- Resistance Level
- CRDF $4.42
- FRST $10.30
- Average True Range (ATR)
- CRDF 0.34
- FRST 0.37
- MACD
- CRDF -0.03
- FRST 0.05
- Stochastic Oscillator
- CRDF 34.41
- FRST 52.21
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, it focuses on making loans secured majorly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in a number of industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts and certificates of deposit.